Plasma Protease C1-inhibitor Treatment Market driven by Rising Prevalence of Angioedema Disorders
by Plasma protease C1-inhibitor treatment is a type of plasma-derived protease inhibitor that is used to treat hereditary angioedema (HAE), a rare genetic condition characterized by …